PURPLE BIOTECH LTD-ADR (PPBT)
US74638P1093 - ADR
| MRQ (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.44M | 15.03M | 10.89M | 11.25M | 4.38M | |||
| Marketable Securities | 862.00K | 17.08M | 36.31M | 46.56M | 2.01M | |||
| Receivables | N/A | N/A | 0.00 | 500.00K | 1.49M | |||
| Other Current Assets | 638.00K | 1.14M | 1.27M | 977.00K | 414.00K | |||
| Total Current Assets | 6.94M | 33.26M | 48.47M | 59.28M | 8.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 325.00K | 682.00K | 896.00K | 968.00K | 244.00K | |||
| Investments And Advances | N/A | 0.00 | 347.00K | 3.07M | N/A | |||
| Intangibles | 27.84M | 20.68M | 20.48M | 20.48M | 6.17M | |||
| Other Non-Current Assets | N/A | N/A | 160.00K | 0.00 | N/A | |||
| Total Non-Current Assets | 28.17M | 21.37M | 21.73M | 24.52M | 6.42M | |||
| TOTAL ASSETS | 35.10M | 54.62M | 70.20M | 83.80M | 14.72M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 184.00K | 194.00K | 199.00K | 207.00K | 195.00K | |||
| Accrued Expenses | N/A | N/A | 1.97M | 1.65M | 1.11M | |||
| Accounts Payable | 3.71M | 2.13M | 1.49M | 1.24M | 1.28M | |||
| Other Current Liabilities | 1.56M | 4.73M | 593.00K | 0.00 | 961.00K | |||
| Total Current Liabilities | 5.46M | 7.06M | 4.25M | 3.10M | 3.55M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 38.00K | 321.00K | 550.00K | 688.00K | 28.00K | |||
| Other Non-Current Liabilities | 141.00K | 145.00K | 292.00K | 265.00K | 285.00K | |||
| Total Non-Current Liabilities | 235.00K | 653.00K | 1.12M | 1.32M | 751.00K | |||
| TOTAL LIABILITIES | 5.69M | 7.71M | 5.37M | 4.41M | 4.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -114.23M | -79.49M | -59.12M | -39.52M | -36.56M | |||
| Additional Paid In Capital | 143.65M | 126.41M | 123.95M | 118.91M | 46.99M | |||
| Minority Interest | 56.00K | 187.00K | 279.00K | 363.00K | 438.00K | |||
| Common Shares | 0.00 | 0.00 | 0.00 | N/A | 0.00 | |||
| Other Shareholders' Equity | -2.00K | -6.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 3.54M | 1.78M | 1.72M | 1.66M | 188.74K | |||
| Tangible Book Value per Share | 0.00 | 0.14 | 0.25 | 0.34 | 0.22 | |||
| Total Shareholders' Equity | 29.41M | 46.91M | 64.83M | 79.39M | 10.42M | |||
| TOTAL LIABILITIES AND EQUITY | 35.10M | 54.62M | 70.20M | 83.80M | 14.72M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | |||
| Current Ratio | 1.27 | 4.71 | 11.41 | 19.14 | 2.34 | |||
| Return On Assets (ROA) | -33.21% | -39.67% | -26.19% | -33.41% | -39.75% | |||
| Return On Equity (ROE) | -39.64% | -46.19% | -28.36% | -35.27% | -56.14% | |||
All data in USD , ROIC based on taxRate of 0.25